You just read:

Belite Bio Announces FDA Approval of Investigational New Drug (IND) for Phase 1 Clinical Trial of LBS-008 to Treat Macular Degeneration and Stargardt Disease

News provided by

Belite Bio, Inc

Apr 24, 2019, 10:15 ET